[APLS] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 36.84%
YoY- 46.64%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 146,377 22,663 60,290 250,000 -142 12 12 379.44%
PBT -87,153 -167,462 -147,581 80,110 -113,217 -36,459 -18,256 29.74%
Tax 1,423 -1,471 352 2 3,981 2,383 -17,896 -
NP -88,576 -165,991 -147,933 78,265 -113,217 -36,459 -18,256 30.09%
Tax Rate - - - -0.00% - - - -
Total Cost 234,953 188,654 208,223 171,735 113,075 36,471 18,267 53.03%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -60.51 -732.43 -245.37 31.31 79,646.45 -315,885.24 -158,169.26 -73.04%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.73 -1.50 -1.73 0.99 -1.54 -0.65 -0.36 12.49%
EPS Diluted -0.73 -1.50 -1.73 0.99 -1.54 -0.63 -0.36 12.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.